ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 03 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide
Shining new light on immunotherapy for breast cancer 12 May 2021 Research shows some breast cancer types may benefit from immunotherapy, but new trial designs are needed to evaluate this potential. Find out more Show/Hide
“Being told I had the BRCA2 mutation effectively saved my life” – Tony’s story 23 Dec 2020 After both he and his sister were diagnosed with breast cancer, Tony Herbert decided to undergo genetic testing to see if he had a BRCA mutation. Here he talks about how the result may have saved his life. Find out more Show/Hide
Weighing in on breast cancer risk – considering the effect of weight gain before the menopause 13 Mar 2020
NCRI 2019: Making research count for patients – reflecting on a fascinating first day at the UK’s biggest cancer conference 04 Nov 2019
Three ways global links help our researchers carry out life-changing research on World Cancer Research Day 24 Sep 2019